DK0871438T3 - Anvendelse af alfa-hydroxysyrer ved fremstillingen af et medikament til behandling af inflammation - Google Patents

Anvendelse af alfa-hydroxysyrer ved fremstillingen af et medikament til behandling af inflammation

Info

Publication number
DK0871438T3
DK0871438T3 DK96920846T DK96920846T DK0871438T3 DK 0871438 T3 DK0871438 T3 DK 0871438T3 DK 96920846 T DK96920846 T DK 96920846T DK 96920846 T DK96920846 T DK 96920846T DK 0871438 T3 DK0871438 T3 DK 0871438T3
Authority
DK
Denmark
Prior art keywords
inflammation
medicament
manufacture
treatment
hydroxy acids
Prior art date
Application number
DK96920846T
Other languages
Danish (da)
English (en)
Inventor
Hakon Westermarck
Pentti Hietala
Maire Jaarma
Timo Sorsa
Martti Vaara
Original Assignee
Extracta Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI953090A external-priority patent/FI953090A0/fi
Application filed by Extracta Ltd filed Critical Extracta Ltd
Application granted granted Critical
Publication of DK0871438T3 publication Critical patent/DK0871438T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96920846T 1995-06-21 1996-06-20 Anvendelse af alfa-hydroxysyrer ved fremstillingen af et medikament til behandling af inflammation DK0871438T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI953090A FI953090A0 (fi) 1995-06-21 1995-06-21 Foerfarande foer framstaellning av alfahydroxidsyra eller en produkt som innehaoller den, och dess onvaendning samt vaordmetod
FI962602A FI119543B (fi) 1995-06-21 1996-06-20 Alfa-hydroksihappojen käyttö valmistettaessa lääkettä tulehduksen hoitoon
PCT/FI1996/000363 WO1997000676A1 (fr) 1995-06-21 1996-06-20 Composes antimicrobiens et anti-inflammatoires

Publications (1)

Publication Number Publication Date
DK0871438T3 true DK0871438T3 (da) 2008-06-30

Family

ID=26159986

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96920846T DK0871438T3 (da) 1995-06-21 1996-06-20 Anvendelse af alfa-hydroxysyrer ved fremstillingen af et medikament til behandling af inflammation

Country Status (6)

Country Link
EP (1) EP0871438B1 (fr)
AU (1) AU6225896A (fr)
DE (1) DE69637449T2 (fr)
DK (1) DK0871438T3 (fr)
FI (1) FI119543B (fr)
WO (1) WO1997000676A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287577B1 (en) 1997-11-12 2001-09-11 The Procter & Gamble Company Leave-on antimicrobial compositions which provide improved residual benefit versus gram positive bacteria
US6183763B1 (en) 1997-06-04 2001-02-06 Procter & Gamble Company Antimicrobial wipes which provide improved immediate germ reduction
US6197315B1 (en) 1997-06-04 2001-03-06 Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria
US5968539A (en) * 1997-06-04 1999-10-19 Procter & Gamble Company Mild, rinse-off antimicrobial liquid cleansing compositions which provide residual benefit versus gram negative bacteria
US6190674B1 (en) 1997-06-04 2001-02-20 Procter & Gamble Company Liquid antimicrobial cleansing compositions
US6214363B1 (en) 1997-11-12 2001-04-10 The Procter & Gamble Company Liquid antimicrobial cleansing compositions which provide residual benefit versus gram negative bacteria
US6210695B1 (en) 1997-06-04 2001-04-03 The Procter & Gamble Company Leave-on antimicrobial compositions
US6190675B1 (en) 1997-06-04 2001-02-20 Procter & Gamble Company Mild, rinse-off antimicrobial liquid cleansing compositions which provide improved residual benefit versus gram positive bacteria
US6284259B1 (en) 1997-11-12 2001-09-04 The Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus Gram positive bacteria
US6183757B1 (en) 1997-06-04 2001-02-06 Procter & Gamble Company Mild, rinse-off antimicrobial cleansing compositions which provide improved immediate germ reduction during washing
US6287583B1 (en) 1997-11-12 2001-09-11 The Procter & Gamble Company Low-pH, acid-containing personal care compositions which exhibit reduced sting
FR2810547B1 (fr) * 2000-06-22 2004-01-30 Pasteur Institut Utilisation d'acides en c2-c10 pour la prevention des infections a bacteries a gram negatif
FR2863168A1 (fr) * 2003-12-04 2005-06-10 Centre Nat Rech Scient Utilisation d'inducteurs de la voie de degradation de la gamma-butyrolactone pour inactiver le signal n-acy homoserine lactone.
WO2020227420A1 (fr) * 2019-05-06 2020-11-12 The General Hospital Corporation Surveillance et modification du microbiome intestinal dans une maladie
FI129515B (en) 2020-11-06 2022-03-31 Salarusta Oy FOR USE IN THE PREVENTION AND / OR TREATMENT OF A DISEASE OR CONDITION RELATED TO THE DEGRADATION AND / OR DISTURBANCE OF THE DEGREE OF MONTOOSASE AND / OR INTEGRITY

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents

Also Published As

Publication number Publication date
FI962602A0 (fi) 1996-06-20
EP0871438B1 (fr) 2008-02-27
DE69637449D1 (de) 2008-04-10
EP0871438A1 (fr) 1998-10-21
FI962602A (fi) 1996-12-22
AU6225896A (en) 1997-01-22
DE69637449T2 (de) 2009-03-12
WO1997000676A1 (fr) 1997-01-09
FI119543B (fi) 2008-12-31

Similar Documents

Publication Publication Date Title
CY2007001I1 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
FI946173A0 (fi) Menetelmä lääkeaineiden antotehon parantamiseksi muunnettujen saponiinien avulla
DE122005000024I2 (de) Darifenacin enthaltende Pharmazeutische zuberreitungen
DK0871438T3 (da) Anvendelse af alfa-hydroxysyrer ved fremstillingen af et medikament til behandling af inflammation
HK1042475A1 (zh) 用於治療炎癥的取代噻唑
EE03512B1 (et) Epinastiin kasutamiseks valude ravis
DK0730864T3 (da) Lægemiddel til behandling af inflammatoriske hjertesygdomme
AU2027695A (en) Pharmaceutical composition for treating stoma-peripheral inflammation diseases
EP0820286A4 (fr) Traitement d'inflammations oculaires
PT777457E (pt) A utilizacao de triacetato de glicerilo para o tratamento de onicomicoses
HK1022269A1 (en) Use of 1-hydroxy-2-pyridones in the manufacture of a medicament for treating skin infections
IL119459A0 (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
NO975660D0 (no) Anvendelse av benzimidazoler for fremstilling av et medikament for behandling av levkemi
GB2319729B (en) A film for topical use in the treatment of wounds
NO984759D0 (no) Anvendelse av en osmolytt ved fremstilling av et medikament for behandling av komplikasjoner forÕrsaket av iskemi
FR2758003B1 (fr) Traitement anti-reflet de surfaces reflectives
DE69618560T2 (de) Medikament gegen ophthalmische erkrankungen
EP0765661A3 (fr) Utilisation de l'acide docosahexaénique pour la fabrication d'un médicament pour le traitement de la glomérulonephrite
EE03437B1 (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
FI964113A (fi) Lääkekoostumus hoitamaan tardiivia dyskinesiaa ja sen käyttö
DK0866699T3 (da) Anvendelse af cholinesteraseinhibitorer til fremstilling af et medikament til behandling af xerostomi
NO990949D0 (no) Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av AIDS
LV11966A (lv) Pretiekaisumu lidzeklis arigai lietosanai
NO986053L (no) Anticonvulsivt virkende derivater for anvendelse ved behandling av psoriasis
NO975554D0 (no) Oral toleranse i hudsykdommer tilstede med T-celle mediert inflammasjon